Hradsky, Ondrej http://orcid.org/0000-0001-6193-0488
Copova, Ivana
Durilova, Marianna
Kazeka, Denis
Lerchova, Tereza
Mitrova, Katarina
Schwarz, Jan
Vetrovcova, Romana
El-Lababidi, Nabil
Karaskova, Eva
Veghova-Velganova, Maria
Sulakova, Astrid
Gonsorčíková, Lucie
Veverkova, Marketa
Zeniskova, Ivana
Zimen, Martin
Bortlik, Martin
Bronsky, Jiri
Article History
Received: 25 May 2023
Revised: 29 August 2023
Accepted: 20 October 2023
First Online: 27 November 2023
Competing interests
: O.H.: lectures/congress fees/consultancy (outside the scope of the submitted work; MSD, AbbVie, Takeda, Sandoz, Nutricia, Nestlé, and Ferring). I.C.: no conflict. M.D.: congress fees (outside the scope of the submitted work; Nutricia, Nestlé). D.K.: congress fee (outside the scope of the submitted work; Takeda). T.L.: lectures/congress fees/consultancy (outside the scope of the submitted work; Ferring, Nutricia, Biocodex, and AbbVie). K.M.: lectures/congress fees/consultancy (outside the scope of the submitted work; Takeda, Janssen-Cilag). J.S.: lectures/congress fees (AstraZeneca, AbbVie, Nestlé, Nutricia, MSD, and Takeda). R.V.: congress fees (outside submitted work; AbbVie, Nestlé). N.L.: lectures/congress fees/consultancy (outside the scope of the submitted work; AbbVie, Sandoz, Nutricia, Nestlé). E.K.: lectures/congress fees/consultancy (outside the scope of the submitted work; AbbVie, Nutricia, and Nestlé). M.V.V.: lectures, congress fees (outside submitted work) - Nestlé, Nutricia. A.S.: Lectures/congress fees/consultancy —AbbVie, Takeda, Nutricia, Nestlé. L.G.: no conflict. M.V.: no conflict. I.Z.: no conflict. M.Z.: no conflict. M.B.: lectures/congress fees/consultancy (outside the scope of the submitted work; Abbvie, Takeda, Janssen-Cilag, Celltrion, Roche, AstraZeneca, Biogen, Tillotts, Ferring, Alfasigma, PRO.MED.CS, Sandoz, Bristol-Myers Squibb, Pfizer, and Swedish Orphan Biovitrum). J.B.: lectures/congress fees/consultancy (outside the scope of the submitted work; MSD, AbbVie, Sandoz, Danone-Nutricia, and Nestlé).
: This study was approved by the Ethics Committee (EK - 440/30) and all parents or participants provided informed consent.